AL-37807 ophthalmic solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL-37807 ophthalmic solution, covering 2008-07-29 to 2008-07-29. Get the full timeline:
Most recent: Clinical Trial Update: Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]